Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma

Tomoko Kitaichi(Kyoto Prefectural University of Medicine), Yoshito Itoh(Fukui-ken Saiseikai Hospital), Yasuyuki Gen(Kyoto Prefectural University of Medicine), Taichiro Nishikawa(Kyoto Prefectural University of Medicine), Atsushi Umemura(University of California San Diego), N. Iwai(Kyoto Prefectural University of Medicine), Yoshio Sumida(Kyoto Prefectural University of Medicine), Yuji Naito(Kyoto Prefectural University of Medicine), Akira Tomie(Kyoto Prefectural University of Medicine), Osamu Dohi(Kyoto Prefectural University of Medicine), Yoh Zen(Unknown), Kanji Yamaguchi(Kyoto Prefectural University of Medicine), Kei Terasaki(Kyoto Prefectural University of Medicine), Nobuhisa Yamada(Kyoto Prefectural University of Medicine), Hironori Mitsuyoshi(Kyoto Prefectural University of Medicine), Kohichiroh Yasui(Kyoto Prefectural University of Medicine), Michihisa Moriguchi(Kyoto Prefectural University of Medicine)
Human Pathology
February 8, 2017
10.1016/j.humpath.2017.01.009
Cited by 7

Related Papers

NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
|Cell|2016|1.1k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
cHCC‐CCA
|Hepatology|2018|333
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282